Loading...

Bright Green Corporation

BGXXNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.04
$0.00(0.00%)

Bright Green Corporation (BGXX) Stock Competitors & Peer Comparison

See (BGXX) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BGXX$0.04+0.00%7.3M-0.76-$0.05N/A
ZTS$155.72+0.07%69.4B26.90$5.82+1.23%
TAK$15.25-0.39%49B53.50$0.29+3.89%
HLN$9.71-1.07%44.6B21.78$0.45+1.79%
TEVA$18.47-1.76%21.2B-123.13-$0.15N/A
ITCI$131.87+0.00%14B-180.64-$0.73N/A
NBIX$135.04-0.18%13.4B40.07$3.38N/A
VTRS$10.54-1.45%12.4B-3.63-$2.93+4.47%
RDY$14.50+0.52%12.1B18.61$0.78+0.63%
CTLT$63.48+0.00%11.5B-27.84-$2.28N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BGXX vs ZTS Comparison August 2025

BGXX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BGXX stands at 7.3M. In comparison, ZTS has a market cap of 69.4B. Regarding current trading prices, BGXX is priced at $0.04, while ZTS trades at $155.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BGXX currently has a P/E ratio of -0.76, whereas ZTS's P/E ratio is 26.90. In terms of profitability, BGXX's ROE is -0.35%, compared to ZTS's ROE of +0.53%. Regarding short-term risk, BGXX is more volatile compared to ZTS. This indicates potentially higher risk in terms of short-term price fluctuations for BGXX.Check ZTS's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;